Respiratory Tract Diseases

9

Review clinical trials related to Respiratory Tract Diseases. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Collection of Lung Fluid and Tissue Samples for Research

This study will collect fluid and tissue specimens from the lungs and nose of healthy people and people with a history of lung infections. The specimens will be examined for differences between the two groups that may be associated with susceptibility to certain infections. Healthy normal volunteers and people with a history of lung infections between 18 and 75 years of age who are followed at NIH may be eligible for this study. Participants undergo the following procedures: Medical history and physical examination. Blood and urine tests. Electrocardiogram (ECG) and chest x-ray. Treadmill exercise stress test (for people over 45 years old with a history of chest pain or ECG abnormalities). Bronchoscopy: The subject s nose and throat are numbed with lidocaine and a sedative is given for comfort. A thin flexible tube called a bronchoscope is advanced through the nose or mouth into the lung airways to examine the airways carefully. Fluid collection during the bronchoscopy using one of the following methods: * Bronchoalveolar lavage: Salt water is injected through the bronchoscope into the lung and immediately suctioned out, washing off cells lining the airways. * Bronchial brushings: A brush-tipped wire enclosed in a sheath is passed through the bronchoscope and a small area of the airway tissue is gently brushed. The brush is withdrawn with some tissue adhering to it. * Endobronchial biopsies: Small pinchers on a wire are passed through the bronchoscope and about 1 to 2 millimeters of tissue is removed. * Nasal scrape: A small device is used to scrape along the inside of the nose to collect some cells. * Sputum induction * Exhaled breath condensate to obtain specimens for in vitro investigations and comparisons of both the cellular and acellular components. * Nasal nitric oxide production * Nasal potential difference * Exhaled aerosol mask sample collection * Cough aerosol collection * Exhaled particle collection * Lung Clearance Index (LCI)

Participants needed: 550
Trial details
Age: 5-100Biological sex: AllType: ObservationalSponsor: National Heart, Lung, and Blood Institute (NHLBI)Updated: Jun 1, 2026Locations: 1
Eligibility criteria

18 to 75 years of age inclusive [+19]

<18 or >75 years old [+75]

Status: Recruiting

Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

The clinical significance of pulmonary embolism (PE) limited to the subsegmental pulmonary arteries, so called isolated subsegmental pulmonary embolism (SSPE), remains controversial. Whether isolated SSPE represents "true" PE, a clinically more benign form of PE, a physiologic lung clearing process, or a false positive result (artifact) is currently unclear and hence, whether patients with isolated SSPE benefit from anticoagulant treatment is uncertain. Despite growing evidence from observational studies that withholding anticoagulation may be a safe option in selected patients with isolated SSPE (i.e., those without concomitant deep vein thrombosis, cancer, etc.), most patients with isolated SSPE receive anticoagulant treatment, which is associated with an increased risk of bleeding. The overall objective of the randomized controlled SAFE-SSPE trial is to evaluate the efficacy and safety of clinical surveillance without anticoagulation compared to anticoagulation treatment in low-risk patients with isolated SSPE.

Participants needed: 276
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Drahomir AujeskyUpdated: May 22, 2026Locations: 40
Eligibility criteria

Informed Consent as documented by signature [+2]

Presence of leg deep vein thrombosis (DVT) or upper extremity DVT (subclavian ve... [+15]

Status: Recruiting

AeviceMD for Detection of Wheeze in Pediatric and Adult Populations

Respiratory signs and symptoms consisting of wheeze, cough, and breathlessness are obtained in a manual fashion through history taking and physical examination by the healthcare professional. Auscultation of the lung assesses airflow through the trachea-bronchial tree and is helpful in diagnosing various respiratory disorders. AeviceMD is a wearable device that can acquire and process lung sounds, thus assisting in the detection of abnormal lung sounds. The primary objective of this study is to determine if AeviceMD can detect wheeze of pediatrics and adults as accurately as a physician through auscultation. The secondary objective is to investigate if AeviceMD can be used for remote auscultation of breath sounds.

Participants needed: 160
Trial details
Age: 3+Biological sex: AllType: ObservationalSponsor: Aevice Health Pte. Ltd.Updated: Oct 3, 2025Locations: 1
Eligibility criteria

The subject is willing and/or parents/guardians are able to give informed consen... [+2]

Any other significant disease or disorder which, in the opinion of the Investiga...

Status: Not yet recruiting

Prospective Cohort of Integrated Traditional Chinese and Western Medicine in China

To further explore the application prospects of integrated Traditional Chinese and Western medicine in chronic disease prevention and control and health management, this study intends to establish a large, prospective, integrated Traditional Chinese and Western medicine cohort in Hubei Province. This study will conduct long-term follow-up and multi-dimensional data collection to systematically reveal the associations between Traditional Chinese Medicine (TCM) constitution types and chronic diseases, the aging process, and multi-morbidity, thereby developing an integrated health management strategy with local characteristics. This study will fill the current gap in systematic evidence linking TCM constitutions to the prevalence of modern diseases, providing a solid demographic and biological foundation for the integrated development of Traditional Chinese and Western medicine. It will also contribute to meeting the needs for early disease warning, early intervention, and personalized care under the "Healthy China" strategic goal.

Participants needed: 1,000,000
Trial details
Age: 30-74Biological sex: AllType: ObservationalSponsor: Huazhong University of Science and TechnologyUpdated: Oct 2, 2025Duration: 10 Years
Eligibility criteria

Not listed

Status: Recruiting

Early Intervention Strategies for Lung Cancer

Low-dose CT (LDCT)can detect and treat lung cancer earlier and more quickly, while expanded screening coverage helps reduce the incidence and mortality of respiratory diseases such as lung cancer. This study aims to conduct a single-arm cluster randomized trial of digitally enabled LDCT in Guangzhou to assess its intervention effectiveness and cost-effectiveness.

Participants needed: 16,000
Trial details
Age: 40-74Biological sex: AllType: InterventionalSponsor: The First Affiliated Hospital of Guangzhou Medical UniversityUpdated: May 30, 2025Locations: 1
Eligibility criteria

The community health service center must be located within one of the 11 distric...

Inclusion Criteria Aged 40-75 years. Residing in the community participating in... [+1]

Status: Not yet recruiting

The Effect of Virtual Reality Goggles and Distraction Cards Applied to Children Aged 6-12 Years During Inhaler Therapy on Physiological Parameters and Anxiety

In the literature, studies examining the effect of virtual reality application on physiological parameters and anxiety during inhalation therapy, which is frequently used in children, are quite limited. Therefore, this study will be conducted to determine the effect of virtual reality goggles and distraction cards on physiological parameters and anxiety in patients receiving inhalation therapy.

Participants needed: 108
Trial details
Age: 6-12Biological sex: AllType: InterventionalSponsor: Uskudar UniversityUpdated: Mar 30, 2025
Eligibility criteria

The child is receiving inhalation (salbutamol) treatment in the pediatric intens... [+6]

The child's clinical treatment is due to a history of surgery, [+4]

Status: Not yet recruiting

MRG-001 as an Immunoregulatory and Regenerative Therapy for ARDS Patients

This is a phase IIa, dose-ranging, proof-of-concept study of MRG-001 in patients with ARDS. The aim is to determine the safety and preliminary efficacy of MRG-001 across two dose ranges.

Participants needed: 60
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: MedRegen LLCUpdated: Aug 23, 2024
Eligibility criteria

Chest x-ray (CXR)* revealing bilateral infiltrates involving a minimum of three... [+2]

Age less than 18 years. [+9]

Status: Recruiting

M. Avium WGS During Mav-PD Treatment

This is a prospective observational study using whole genome sequencing (WGS) to investigate whether new strains (other than the initially identified strain(s)) of M. avium are responsible for persistently culture positive sputum during treatment (refractory disease), or the reversion to culture positive sputum after prior conversion to negative. The study will further investigate for differences between participants living in the Toronto/York region versus participants living elsewhere. The primary goal of this prospective observational study is to understand why some patients with M. avium lung disease have persistent or recurrent M. avium in their sputum despite treatment. The aim is to understand whether it is usually due to treatment failure or new infection.

Participants needed: 40
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Health Network, TorontoUpdated: May 21, 2024Locations: 1
Eligibility criteria

Age 18 and older [+4]

Lack of an available pre-treatment M. avium isolate in the PHOL isolate bank [+9]

Status: Recruiting

A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC

This is an open-label, single arm Phase II study designed to evaluate the efficacy and safety of adebelizumab combined with carboplatin/Cisplatin plus (+) etoposide and concurrent radiotherapy in the first-line treatment of patients with extensive stage oligometastatic small cell lung cancer.

Participants needed: 62
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Nanfang Hospital, Southern Medical UniversityUpdated: Dec 20, 2023Locations: 1
Eligibility criteria

Signed inform consent form [+6]

Spinal cord compression not definitively treated with surgery and/or radiation o... [+12]